Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study. Valkhoff, V. E., Van Soest, E. M., Mazzaglia, G., Molokhia, M., Schade, R., Trifiro, G., Goldstein, J. L., Hernandez-Diaz, S., Kuipers, E. J., & Sturkenboom, M. C. J. M. Arthritis and Rheumatism, 64(8):2792-2802 , DOI = 10.1002/art.34433, 2012.
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study [link]Paper  bibtex   
@article{RN440,
   author = {Valkhoff, V. E. and Van Soest, E. M. and Mazzaglia, G. and Molokhia, M. and Schade, R. and Trifiro, G. and Goldstein, J. L. and Hernandez-Diaz, S. and Kuipers, E. J. and Sturkenboom, M. C. J. M.},
   title = {Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study},
   journal = {Arthritis and Rheumatism},
   volume = {64},
   number = {8},
   pages = {2792-2802 , DOI = 10.1002/art.34433},
   url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864115219&doi=10.1002%2fart.34433&partnerID=40&md5=6e0f9dcd7968e09131708f6438f9c6d8},
   year = {2012},
   type = {Journal Article}
}

Downloads: 0